semaglutide vs terzepatide A new headline out about the investigational drug tirzepatide was published this week. This medicine is a dual GLP-1/GIP agonist. The average weight loss on the high dose over 72 weeks was Switching between weight-loss medications -
Pay in 4 interest-free payments of $6.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8


























